Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up - Should You Buy?

Key Points

• Nihon Kohden Corporation's stock gapped up from a previous close of $11.18 to an opening price of $12.10, eventually last trading at $11.49.
• The company reported earnings of $0.18 per share for its last quarter, with revenue totaling $439.11 million and a net margin of 6.23%.
• Nihon Kohden specializes in developing and manufacturing medical electronic equipment, offering products such as patient monitoring systems and defibrillators internationally.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $11.18, but opened at $12.10. Nihon Kohden shares last traded at $11.49, with a volume of 1,313 shares trading hands.

Nihon Kohden Stock Up 3.1%

The firm has a market capitalization of $1.97 billion, a price-to-earnings ratio of 20.59 and a beta of 0.35. The business has a 50-day moving average of $12.20 and a two-hundred day moving average of $13.19.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported $0.18 earnings per share for the quarter. The firm had revenue of $439.11 million for the quarter. Nihon Kohden had a net margin of 6.23% and a return on equity of 7.20%.

Nihon Kohden Company Profile

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.